Rituximab for Steroid-Dependent Minimal Change Disease in Adults: Is It Time for a Change?

Minimal change disease (MCD) is a common cause of nephrotic syndrome, and steroid treatment is usually effective at the expense of adverse effects and frequent relapses. Rituximab, a monoclonal antibody against cluster of differentiation (CD)20 B-lymphocytes, leads to depletion of B-cells and has be...

Descripción completa

Detalles Bibliográficos
Autor principal: Kannan, Lakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933270/
https://www.ncbi.nlm.nih.gov/pubmed/35350528
http://dx.doi.org/10.7759/cureus.22313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933270/
https://www.ncbi.nlm.nih.gov/pubmed/35350528
http://dx.doi.org/10.7759/cureus.22313

Ejemplares similares